• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自噬小分子调节剂及其潜在的治疗应用。

Small-molecule regulators of autophagy and their potential therapeutic applications.

机构信息

State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, P.R. China.

出版信息

ChemMedChem. 2013 May;8(5):694-707. doi: 10.1002/cmdc.201200560. Epub 2013 Apr 8.

DOI:10.1002/cmdc.201200560
PMID:23568434
Abstract

Autophagy is a highly conserved process in which damaged proteins and organelles are sequestered in double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. As an efficient response to cellular stress, autophagy is essential for the maintenance of cellular homeostasis. Defective autophagy is associated with a variety of diseases, including cancer. This article summarizes current knowledge about the molecular mechanism of autophagy and its role in tumorigenesis. Particular focus is placed on the development of small-molecule regulators of autophagy and their potential application as anticancer therapeutic agents.

摘要

自噬是一种高度保守的过程,在此过程中,受损的蛋白质和细胞器被隔离在双层膜自噬体中,并递送至溶酶体进行降解和再循环。作为对细胞应激的有效反应,自噬对于维持细胞内稳态至关重要。自噬缺陷与多种疾病有关,包括癌症。本文总结了自噬的分子机制及其在肿瘤发生中的作用的最新知识。特别关注的是自噬小分子调节剂的开发及其作为抗癌治疗剂的潜在应用。

相似文献

1
Small-molecule regulators of autophagy and their potential therapeutic applications.自噬小分子调节剂及其潜在的治疗应用。
ChemMedChem. 2013 May;8(5):694-707. doi: 10.1002/cmdc.201200560. Epub 2013 Apr 8.
2
Pharmacological inhibitors of autophagy as novel cancer therapeutic agents.自噬的药理学抑制剂作为新型癌症治疗剂。
Pharmacol Res. 2016 Mar;105:164-75. doi: 10.1016/j.phrs.2016.01.028. Epub 2016 Jan 28.
3
Autophagy-regulating small molecules and their therapeutic applications.自噬调控小分子及其治疗应用。
Chem Soc Rev. 2012 Apr 21;41(8):3245-63. doi: 10.1039/c2cs15328a. Epub 2012 Jan 31.
4
Nanomedicine for Cancer Therapy Using Autophagy: An Overview.纳米医学在癌症治疗中对自噬作用的应用:综述。
Curr Top Med Chem. 2018;18(30):2599-2613. doi: 10.2174/1568026619666181224104838.
5
The autophagic paradox in cancer therapy.癌症治疗中的自噬悖论。
Oncogene. 2012 Feb 23;31(8):939-53. doi: 10.1038/onc.2011.295. Epub 2011 Jul 18.
6
The emerging role of CXC chemokines and their receptors in cancer.CX 趋化因子及其受体在癌症中的新作用。
Future Med Chem. 2012 May;4(7):853-67. doi: 10.4155/fmc.12.48.
7
Autophagy: shaping the tumor microenvironment and therapeutic response.自噬:塑造肿瘤微环境和治疗反应。
Trends Mol Med. 2013 Jul;19(7):428-46. doi: 10.1016/j.molmed.2013.04.005. Epub 2013 May 25.
8
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.缺氧诱导因子 (HIF)-1 抑制剂的最新进展。
Eur J Med Chem. 2012 Mar;49:24-40. doi: 10.1016/j.ejmech.2012.01.033. Epub 2012 Jan 24.
9
Autophagy in cancer: good, bad, or both?癌症中的自噬:有益、有害,还是兼而有之?
Cancer Res. 2006 Oct 1;66(19):9349-51. doi: 10.1158/0008-5472.CAN-06-1597.
10
The role of autophagy in anticancer therapy: promises and uncertainties.自噬在抗癌治疗中的作用:前景与不确定性。
J Intern Med. 2010 Nov;268(5):410-8. doi: 10.1111/j.1365-2796.2010.02266.x.

引用本文的文献

1
FYCO1 Peptide Analogs: Design and Characterization of Autophagy Inhibitors as Co-Adjuvants in Taxane Chemotherapy of Prostate Cancer.FYCO1肽类似物:自噬抑制剂作为前列腺癌紫杉烷化疗辅助剂的设计与表征
Int J Mol Sci. 2025 Jun 3;26(11):5365. doi: 10.3390/ijms26115365.
2
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines.新型环状肽的计算设计,赋予其在癌细胞系中抑制自噬的活性。
Int J Mol Sci. 2024 Apr 24;25(9):4622. doi: 10.3390/ijms25094622.
3
Gut microbiota-derived butyrate restores impaired regulatory T cells in patients with AChR myasthenia gravis via mTOR-mediated autophagy.
肠道微生物衍生的丁酸盐通过 mTOR 介导的自噬恢复重症肌无力患者中受损的调节性 T 细胞。
Cell Commun Signal. 2024 Apr 3;22(1):215. doi: 10.1186/s12964-024-01588-9.
4
Rescue of lysosomal function as therapeutic strategy for SPG15 hereditary spastic paraplegia.溶酶体功能拯救作为 SPG15 遗传性痉挛性截瘫的治疗策略。
Brain. 2023 Mar 1;146(3):1103-1120. doi: 10.1093/brain/awac308.
5
Targeting Drug Chemo-Resistance in Cancer Using Natural Products.利用天然产物靶向治疗癌症的化疗耐药性。
Biomedicines. 2021 Sep 29;9(10):1353. doi: 10.3390/biomedicines9101353.
6
Emerging roles of nucleotide metabolism in cancer development: progress and prospect.核苷酸代谢在癌症发生中的新兴作用:进展与展望。
Aging (Albany NY). 2021 May 5;13(9):13349-13358. doi: 10.18632/aging.202962.
7
Development of CDK4/6 Inhibitors: A Five Years Update.CDK4/6 抑制剂的研发进展:五年回顾。
Molecules. 2021 Mar 9;26(5):1488. doi: 10.3390/molecules26051488.
8
Costunolide Induces Autophagy and Apoptosis by Activating ROS/MAPK Signaling Pathways in Renal Cell Carcinoma.木香烃内酯通过激活肾细胞癌中的ROS/MAPK信号通路诱导自噬和凋亡。
Front Oncol. 2020 Oct 26;10:582273. doi: 10.3389/fonc.2020.582273. eCollection 2020.
9
2-Aminoethoxydiphenylborane sensitizes anti-tumor effect of bortezomib via suppression of calcium-mediated autophagy.2-氨乙氧基二苯硼烷通过抑制钙介导的自噬增强硼替佐米的抗肿瘤作用。
Cell Death Dis. 2018 Mar 2;9(3):361. doi: 10.1038/s41419-018-0397-0.
10
Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis.氯喹和羟氯喹通过靶向基础自噬和增强细胞凋亡来抑制膀胱癌细胞生长。
Kaohsiung J Med Sci. 2017 May;33(5):215-223. doi: 10.1016/j.kjms.2017.01.004. Epub 2017 Feb 28.